GLAUKOS Corp — Director's Dealing 2024

Feb 12, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GLAUKOS Corp (GKOS)
CIK: 0001192448
Period of Report: 2024-02-08

Reporting Person: Gilliam Joseph E (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-02-08	Common Stock	M	5000	$39.10	Acquired	124802	Direct
2024-02-08	Common Stock	S	5000	$96.07	Disposed	119802	Direct
2024-02-09	Common Stock	M	631	$55.18	Acquired	120433	Direct
2024-02-09	Common Stock	S	631	$96.70	Disposed	119802	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-02-08	Stock Option (Right to Buy)	$39.10	M	5000	Disposed	2030-03-12	Common Stock (5000)	Direct
2024-02-09	Stock Option (Right to Buy)	$55.18	M	631	Disposed	2032-03-24	Common Stock (631)	Direct

Footnotes

F1: Includes 81,885 restricted stock units that have not yet vested or been delivered to the Reporting Person.

F2: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2023.

F3: This transaction was executed in multiple trades at prices ranging from $96.01 to $96.38. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F4: This transaction was executed in multiple trades at prices ranging from $96.57 to $97.02. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F5: The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2023.

F6: This option was granted on March 12, 2020 and had a four-year vesting schedule in which 25% vested on the first anniversary of the grant date and the
remainder vested in equal monthly installments for 36 months thereafter, such that the stock option vested in full on the four-year anniversary of the grant
date.

F7: Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 24, 2022, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period.